Image

Global Whole Genome and Exome Sequencing Market - Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • May 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • May 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Whole Genome and Exome Sequencing Market, By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing and Others), Products and Services (Products, Systems, Kits, Services, Sequencing Services, Data Analysis Services and Others), Applications (Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research and Others), End User (Research Center, Academic and Government Institutions, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies and Others) - Industry Trends and Forecast to 2029.

Whole Genome and Exome Sequencing Market

Market Analysis and Size                   

Genomic research has had a huge impact on health care over the years. The genomics revolution has accelerated the transformation of medicine and biomedical sciences. Costs for Whole Genome Sequencing are falling, prompting a gold rush for market participants. New consumers, new technologies, and new specialities are all on the rise. A wide range of well-funded players is competing for market share on a genuinely global arena, in a setting reminiscent of the emergence of the internet business.

Data Bridge Market Research analyses that the whole genome and exome sequencing market was valued at a USD 1080.16 million in 2021 and is further estimated to reach USD 7310 million by 2029, and is expected to grow at a CAGR of 27% during the forecast period of 2022 to 2029.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing and Others), Products and Services (Products, Systems, Kits, Services, Sequencing Services, Data Analysis Services and Others), Applications (Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research and Others), End User (Research Center, Academic and Government Institutions, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

DIGIRAD CORPORATION (US), Neusoft Corporation (China), CANON MEDICAL SYSTEMS CORPORATION (Japan), SurgicEye GmbH (Germany), Mediso Ltd. (Hungary), CMR Naviscan. (US), DDD-Diagnostic A/S (Denmark), Absolute Imaging Inc. (Canada), Bartec Technologies Ltd. (UK), BCL X-Ray Canada Inc. (Canada), TTG Imaging Solutions, LLC (US), Mirion Technologies (Capintec), Inc. (US), LANDAUER (US), Ashby Gorman Baker Ltd. (Belgium), Lucerno Dynamics, LLC. (US), Berthold Technologies GmbH & Co.KG (Germany), Incom, Inc. (US), Siemens (US), Koninklijke Philips N.V. (Netherlands), and Spectrum Dynamics Medical (Switzerland).

Market Opportunities

  • Rapidly lowering sequencing prices
  • Increasing consumer uptake of WES technology
  • Strategic alliances between important businesses and research institutes
  • Increased use of WES technology for new scientific applications

Market Definition

The whole genome sequencing helps to provide rich information regarding single nucleotide, structural, or copy number variants, while exome sequencing often makes more sense when time or resources are limited. Exome sequencing is also known as whole exome sequencing (WES), and is a genomic procedure for sequencing all of the protein-coding regions of genes in a genome.

Whole Genome and Exome Sequencing Market Dynamics                   

Drivers

Major factors that are expected to boost the growth of the whole genome and exome sequencing market in the forecast period are as follows:

  • Rise in the prevalence of cancer

The most major element driving this market's growth is the rise in cancer incidence and expanding uses of next-generation sequencing in cancer research.

  • Low cost and high speed of the Wes technology

When compared to whole genome sequencing, whole exome sequencing has a lower cost which will further anticipated to propel the growth of the market.

  • Rise in the acceptance of next-generation sequencing methods

The total market is being driven by a growth in acceptability of next-generation sequencing approaches for the prediction, treatment, and monitoring of a variety of chronic diseases, such as cancer.

Opportunities

In addition, the growing adoption of personalized medicine is further estimated to provide potential opportunities for the growth of the whole genome and exome sequencing market in the coming years.

Restraints/Challenges

On the other hand, the dearth of skilled professionals and high reliability on grants is further projected to impede the growth of the whole genome and exome sequencing market in the targeted period. However, the ethical and legal concerns regarding to whole exome sequencing might further challenge the growth of the whole genome and exome sequencing market in the near future.

This whole genome and exome sequencing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the whole genome and exome sequencing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Whole Genome and Exome Sequencing Market

The pandemic of COVID-19 has had a huge impact on the whole genome and exome sequencing market. The large spectrum of genomic products utilised in COVID-19 research to better understand the coronavirus propelled the market's expansion. Using existing genetic datasets, researchers aimed to address genetic severity and susceptibility to SARS-CoV-2 infection. The common variations underlying host-pathogen interactions and biological networks have been discovered using genome-wide association studies (GWAS) and multiomic-based techniques. However, in the post-COVID scenario, the whole genome and exome sequencing market is projected to be significantly impacted.

Recent Development

  • In January 2020, The "Genome India Project" was started by the Department of Biotechnology (DBT) (GIP). The goal of the initiative is to collect 10,000 genetic samples from Indian residents in order to create a reference genome. Precision health, rare genetic illnesses, the mutation spectrum of genetic and complex diseases in the Indian population, genetic epidemiology of multifactorial lifestyle diseases, and translational research are some of the areas of attention for this project.

Global Whole Genome and Exome Sequencing Market Scope and Market Size

The whole genome and exome sequencing market is segmented on the basis of technology, products and services, applications and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Others

On the basis of technology, the whole genome and exome sequencing market is segmented into sequencing by synthesis, ion semiconductor sequencing and others.

Products and Services

  • Products
  • Systems
  • Kits
  • Services
  • Sequencing Services
  • Data Analysis Services
  • Others

On the basis of products and services, the whole genome and exome sequencing market is segmented into products, systems, kits, services, sequencing services, data analysis services and others. Kits has been further sub segmented into DNA fragmentation end repair, a-tailing and size selection, library preparation kits and target enrichment kits.

Applications                                                         

  • Diagnostics
  • Cancer
  • Monogenic Disorders
  • Diabetes
  • Drug Discovery and Development
  • Personalized Medicine
  • Agriculture and Animal Research
  • Others

On the basis of applications, the whole genome and exome sequencing market is segmented into diagnostics, cancer, monogenic disorders, diabetes, drug discovery and development, personalized medicine, agriculture and animal research and others.

End user

  • Research Center
  • Academic and Government Institutions
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

On the basis of end user, the whole genome and exome sequencing market is segmented into research center, academic and government institutions, hospitals and clinics, pharmaceutical and biotechnology companies and others.

Whole Genome and Exome Sequencing Market Regional Analysis/Insights  

The whole genome and exome sequencing market is analysed and market size insights and trends are provided by country, technology, products and services, applications and end user as referenced above.

The countries covered in the whole genome and exome sequencing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the whole genome and exome sequencing market due to the rise in the incidence of genetic and chronic disorders, including cancer. Furthermore, the growing of the geriatric population and increasing demand for targeted and personalized medicine will further boost the growth of the whole genome and exome sequencing market in the region during the forecast period.

Asia-Pacific is projected to observe significant amount of growth in the whole genome and exome sequencing market due to the regular government funding. Moreover, the growing numbers of conferences regarding the whole exome sequencing technique is further anticipated to propel the growth of the whole genome and exome sequencing market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The whole genome and exome sequencing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for whole genome and exome sequencing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the whole genome and exome sequencing market. The data is available for historic period 2010-2020.

Competitive Landscape and Whole Genome and Exome Sequencing Market Share Analysis

The whole genome and exome sequencing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to whole genome and exome sequencing market.

 Some of the major players operating in the whole genome and exome sequencing market are:

  • 10x Genomics, Inc. (US)
  • 23andME Inc. (US)
  • Abbott (US)
  • AccuraGen Inc. (US)
  • Adaptive Biotechnologies (US)
  • Admera Health, LLC (US)
  • Agena Bioscience, Inc. (US)
  • Agilent Technologies, Inc. (US)
  • Akonni Biosystems, Inc. (US)
  • Ancestry (US)
  • Anchor Dx (China)
  • ARUP Laboratories (US)
  • Asuragen (US)
  • Baylor Genetics (US)
  • Beckman Coulter, Inc. (US)
  • BD (US)
  • BGI Genomics (China)
  • Bioarray S.L. (US)
  • Biocept, Inc. (US)


SKU-
Why Choose Us


Frequently Asked Questions

The market value for Whole Genome and Exome Sequencing Market is expected USD 7310 million by 2029.
The Whole Genome and Exome Sequencing Market is to grow at a CAGR of 27% during the forecast period of 2022 to 2029.
On the basis of application, the Whole Genome and Exome Sequencing Market is segmented into Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research and Others.
On the basis of product, the Whole Genome and Exome Sequencing Market is segmented into Products, Systems, Kits, Services, Sequencing Services, Data Analysis Services and Others.